Understanding the Role of Systemic Inflammation in Alzheimer’s Disease

Kynurenines in the mammalian brain: when physiology meets pathology

Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530

Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study

Walker, K. A., Gottesman, R. F., Wu, A., Knopman, D. S., Gross, A. L., Mosley, T. H., Selvin, E., & Windham, B. G. (2019) · Neurology · doi:10.1212/wnl.0000000000007094 · Cited by 282

Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research

Cunningham, C., & Hennessy, E. (2015) · Alzheimer's Research & Therapy · doi:10.1186/s13195-015-0117-2 · Cited by 211

Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study

Walker, K. A., Hoogeveen, R. C., Folsom, A. R., Ballantyne, C. M., Knopman, D. S., Windham, B. G., Jack, C. R., & Gottesman, R. F. (2017) · Neurology · doi:10.1212/wnl.0000000000004688 · Cited by 150

The association of mid-to late-life systemic inflammation with white matter structure in older adults: The Atherosclerosis Risk in Communities Study

Walker, K. A., Windham, B. G., Power, M. C., Hoogeveen, R. C., Folsom, A. R., Ballantyne, C. M., Knopman, D. S., Selvin, E., Jack, C. R., & Gottesman, R. F. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.03.031 · Cited by 93

Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation

Chen, Y., & Yu, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02853-3 · Cited by 516

Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus

Bettcher, B. M., Tansey, M. G., Dorothée, G., & Heneka, M. T. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00549-x · Cited by 427

Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review

Twarowski, B., & Herbet, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076518 · Cited by 489

Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs

Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. V. D. S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115522 · Cited by 375

Neuroprotective effect of SGLT2 inhibitors.

Pawlos, A., Broncel, M., Woźniak, E., & Gorzelak-Pabiś, P. (2021) · Molecules · doi:10.3390/molecules26237213 · Cited by 304

Multitarget approach for natural products in inflammation

Jude, S., & Gopi, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819218-4.00004-3 · Cited by 176

Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota

Qian, X.-H., Song, X.-X., Liu, X.-L., Chen, S.-D., & Tang, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101317 · Cited by 153

Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels

Cunha, S., Forbes, B., Lobo, J. M. S., & Silva, A. C. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s305851 · Cited by 157

Overview of anti-inflammatory diets and their promising effects on non-communicable diseases

Yu, X., Pu, H., & Voss, M. (2024) · British Journal of Nutrition · doi:10.1017/s0007114524001405 · Cited by 134

Neuropathogenesis-on-chips for neurodegenerative diseases

Amartumur, S., Nguyen, H. M., Huynh, T., Kim, T. S., Woo, R., Oh, E., Kim, K. K., Lee, L. P., & Heo, C. (2024) · Nature Communications · doi:10.1038/s41467-024-46554-8 · Cited by 131

Phosphatidylcholine Ameliorates LPS-Induced Systemic Inflammation and Cognitive Impairments via Mediating the Gut–Brain Axis Balance

Tan, W., Zhang, Q., Dong, Z., Yan, Y., Fu, Y., Liu, X., Zhao, B., & Duan, X. L. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06383 · Cited by 113

Systems Age: a single blood methylation test to quantify aging heterogeneity across 11 physiological systems

Sehgal, R., Markov, Y., Qin, C., Meer, M., Hadley, C., Shadyab, A. H., Casanova, R., Manson, J. E., Bhatti, P., Moore, A. Z., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00958-3 · Cited by 79

Microbial Infections Are a Risk Factor for Neurodegenerative Diseases

Lotz, S. K., Blackhurst, B. M., Reagin, K. L., & Funk, K. E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.691136 · Cited by 100

Does Low Grade Systemic Inflammation Have a Role in Chronic Pain?

Zhou, W. B. S., Meng, J., & Zhang, J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.785214 · Cited by 89

Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease

Semba, R. D. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa024 · Cited by 78

Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?

Verkhratsky, A., Li, Q., Melino, S., Melino, G., & Shi, Y. (2020) · Biology Direct · doi:10.1186/s13062-020-00282-3 · Cited by 81

Neuropathological Mechanisms Associated with Pesticides in Alzheimer’s Disease

Tang, B. L. (2020) · Toxics · doi:10.3390/toxics8020021 · Cited by 84

The Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives

Alexaki, V. I. (2021) · Cells · doi:10.3390/cells10071584 · Cited by 84

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease

Munawara, U., Catanzaro, M., Xu, W., Tan, C., Hirokawa, K., Bosco, N., Dumoulin, D., Khalil, A., Larbi, A., Lévesque, S., et al. (2021) · Immunity & Ageing · doi:10.1186/s12979-021-00236-x · Cited by 74

The impact of neuroinflammation on neuronal integrity

Tastan, B., & Heneka, M. T. (2024) · Immunological Reviews · doi:10.1111/imr.13419 · Cited by 81

Diet’s Role in Modifying Risk of Alzheimer’s Disease: History and Present Understanding

Grant, W. B., & Blake, S. M. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230418 · Cited by 82

The effect of probiotics on cognitive function across the human lifespan: A systematic review

Eastwood, J., Walton, G., van Hemert, S., Williams, C. M., & Lamport, D. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.032 · Cited by 65

Low-grade peripheral inflammation affects brain pathology in the AppNL-G-Fmouse model of Alzheimer’s disease

Xie, J., Gorlé, N., Vandendriessche, C., Imschoot, G. V., Wonterghem, E. V., Cauwenberghe, C. V., Parthoens, E., Hamme, E. V., Lippens, S., Hoecke, L. V., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01253-z · Cited by 69

Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases

Yeo, X. Y., Cunliffe, G., Ho, R., Lee, S. S., & Jung, S. (2022) · Biomedicines · doi:10.3390/biomedicines10020343 · Cited by 66

A Critical Review of the Study of Neuroprotective Diets to Reduce Cognitive Decline

Duplantier, S. C., & Gardner, C. D. (2021) · Nutrients · doi:10.3390/nu13072264 · Cited by 55

Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology

Hou, J., Ou, Y., Xu, W., Zhang, P., Tan, L., Yu, J., & Initiative, O. B. O. A. D. N. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00968-y · Cited by 57

Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages

Nolan, R. A., Reeb, K. L., Rong, Y., Matt, S. M., Johnson, H. S., Runner, K., & Gaskill, P. J. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100030 · Cited by 54

COVID-19 severity is related to poor executive function in people with post-COVID conditions

Ariza, M., Cano, N., Segura, B., Adán, A., Bargalló, N., Caldú, X., Campabadal, A., Jurado, M. Á., Mataró, M., Pueyo, R., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11587-4 · Cited by 53

Prenatal disruption of blood–brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation

Zhao, Q., Dai, W., Chen, H. Y., Jacobs, R. E., Zlokovic, B. V., Lund, B. T., Montagne, A., & Bonnin, A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113310119 · Cited by 52

Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model

Rossano, S. M., Johnson, A. S., Smith, A. P., Ziaggi, G., Roetman, A. E., Guzman, D., Okafor, A., Klein, J., Tomljanovic, Z., Stern, Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13699 · Cited by 54

Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults

Walker, K. A., Gross, A. L., Moghekar, A., Soldan, A., Pettigrew, C. A., Hou, X., Lu, H., Alfini, A. J., Bilgel, M., Miller, M. I., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.006 · Cited by 52

Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer’s disease via impacting on peripheral innate immune cells

Shi, M., Chu, F., Zhu, F., & Zhu, J. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03003-5 · Cited by 52

Aluminum-induced generation of lipopolysaccharide (LPS) from the human gastrointestinal (GI)-tract microbiome-resident Bacteroides fragilis

Alexandrov, P. N., Hill, J. M., Zhao, Y., Bond, T., Taylor, C. M., Percy, M. E., Li, W., & Lukiw, W. J. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110886 · Cited by 47

DAT and TH expression marks human Parkinson’s disease in peripheral immune cells

Gopinath, A., Mackie, P. M., Hashimi, B., Buchanan, A. M., Smith, A. R., Bouchard, R. S., Shaw, G., Badov, M., Saadatpour, L., Gittis, A. H., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00333-8 · Cited by 47

Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study

Yau, Y. F., Cheah, I. K.-M., Mahendran, R., Tang, R. M. Y., Chua, R. Y., Goh, R. E. S., Feng, L., Li, J., Kua, E. H., Chen, C., et al. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241291253 · Cited by 48

The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer’s Disease

Webberley, T. S., Masetti, G., Bevan, R. J., Kerry-Smith, J., Jack, A. A., Michael, D. R., Thomas, S., Glymenaki, M., Li, J., McDonald, J. A. K., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.843105 · Cited by 46

The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction

Li, Z.-H., Jiang, Y., Long, C., Peng, Q., & Yue, R. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14077 · Cited by 41

Proteomics identifies potential immunological drivers of postinfection brain atrophy and cognitive decline

Duggan, M. R., Peng, Z., Sipilä, P. N., Lindbohm, J. V., Chen, J., Lü, Y., Davatzikos, C. A., Erus, G., Hohman, T. J., Andrews, S. J., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00682-4 · Cited by 47

Crosstalk between peripheral inflammation and brain: Focus on the responses of microglia and astrocytes to peripheral challenge

Geloso, M. C., Zupo, L., & Corvino, V. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105872 · Cited by 43

Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review

Yu, C.-C., Du, Y., Wang, S., Liu, L.-B., Shen, F., Wang, L., Lin, Y.-F., & Kong, L.-H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.549772 · Cited by 43

The gut–brain axis in Alzheimer’s disease is shaped by commensal gut microbiota derived extracellular vesicles

Xie, J., Hoecke, L. V., Wonterghem, E. V., Imschoot, G. V., Andries, V., Vereecke, L., & Vandenbroucke, R. E. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2501193 · Cited by 43

Cellular transcriptional alterations of peripheral blood in Alzheimer’s disease

Song, L., Yang, Y., Guo, Q., & Zhao, X. (2022) · BMC Medicine · doi:10.1186/s12916-022-02472-4 · Cited by 40

Incidence of dementia following hospitalization with infection among adults in the Atherosclerosis Risk in Communities (ARIC) study cohort

Bohn, B., Lutsey, P. L., Misialek, J. R., Walker, K. A., Brown, C. H., Hughes, T. M., Ishigami, J., Matsushita, K., & Demmer, R. T. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.50126 · Cited by 35

Usnic acid derivatives as tau-aggregation and neuroinflammation inhibitors

Shi, C., Peng, W., Zhao, J., Yang, H., Qu, L., Wang, C., Kong, L., & Wang, X. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111961 · Cited by 36

Systemic Exposure to Lipopolysaccharide from Porphyromonas gingivalis Induces Bone Loss-Correlated Alzheimer’s Disease-Like Pathologies in Middle-Aged Mice

Gu, Y., Wu, Z., Zeng, F., Jiang, M., Teeling, J. L., Ni, J., & Takahashi, I. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200689 · Cited by 37

Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease

Piniella‐Matamoros, B., Marín‐Prida, J., & Pentón‐Rol, G. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00161-7 · Cited by 34

New quinoline/1,2,4-triazole hybrids as dual inhibitors of COX-2/5-LOX and inflammatory cytokines: Design, synthesis, and docking study

Mohassab, A. M., Hassan, H. A., Abdelhamid, D. S., Gouda, A. M., Gomaa, H. A. M., Youssif, B. G. M., Radwan, M. O., Fujita, M., Otsuka, M., & Abdel‐Aziz, M. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130948 · Cited by 34

Neurologic complications of coronavirus and other respiratory viral infections

Cavallieri, F., Sellner, J., Zedde, M., & Moro, E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91532-8.00004-5 · Cited by 32

Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the App NL – G – F Mouse Model of Alzheimer’s Disease

Sohrabi, M., Pecoraro, H. L., & Combs, C. K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201099 · Cited by 31

Advanced nano delivery system for stem cell therapy for Alzheimer's disease

Pan, Y., Li, L., Cao, N., Liao, J., Chen, H., & Zhang, M. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122852 · Cited by 33

Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer’s Disease and Mild Cognitive Impairment patients

Andreadou, E. G., Katsipis, G., Tsolaki, M., & Pantazaki, A. A. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577561 · Cited by 31

A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer's Disease Studies

de Rijke, T. J., Doting, M. H. E., van Hemert, S., Deyn, P. P. D., Munster, B. C. V., Harmsen, H. J. M., & Sommer, I. E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.879491 · Cited by 32

Inflammatory Potential of Diet Is Associated with Biomarkers Levels of Inflammation and Cognitive Function among Postmenopausal Women

Skoczek-Rubińska, A., Muzsik, A., Chmurzyńska, A., Jamka, M., Walkowiak, J., & Bajerska, J. (2021) · Nutrients · doi:10.3390/nu13072323 · Cited by 32

Circulating Cell-Free Genomic DNA Is Associated with an Increased Risk of Dementia and with Change in Cognitive and Physical Function

Nidadavolu, L. S., Feger, D. M., Wu, Y., Grodstein, F., Gross, A. L., Bennett, D. A., Walston, J. D., Oh, E. S., & Abadir, P. M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220301 · Cited by 30

Thirty Risk Factors for Alzheimer’s Disease Unified by a Common Neuroimmune–Neuroinflammation Mechanism

Weaver, D. F. (2023) · Brain Sciences · doi:10.3390/brainsci14010041 · Cited by 34

Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations

Honorio, P., Sainimnuan, S., Hannongbua, S., & Saparpakorn, P. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109523 · Cited by 29

The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease

Culibrk, R. A., & Hahn, M. S. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.583884 · Cited by 28

Exosomes: A missing link between chronic systemic inflammation and Alzheimer’s disease?

Ozansoy, M., Mikati, H., Velioğlu, H. A., & Yuluğ, B. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114161 · Cited by 30

Increasing Neuroinflammation Relates to Increasing Neurodegeneration in People with HIV

Tavasoli, A., Gelman, B. B., Marra, C. M., Clifford, D. B., Iudicello, J. E., Rubin, L. H., Letendre, S. L., Tang, B., & Ellis, R. J. (2023) · Viruses · doi:10.3390/v15091835 · Cited by 27

Theophylline-based hybrids as acetylcholinesterase inhibitors endowed with anti-inflammatory activity: synthesis, bioevaluation, in silico and preliminary kinetic studies

Elgazar, A. A., El-Domany, R. A., Eldehna, W. M., & Badria, F. A.-E. (2023) · RSC Advances · doi:10.1039/d3ra04867e · Cited by 27

Risk of Dementia in Patients with Diabetes Using Sodium-Glucose Transporter 2 Inhibitors (SGLT2i): A Systematic Review, Meta-Analysis, and Meta-Regression

Gunawan, P. Y., Gunawan, P. A., & Hariyanto, T. I. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01538-1 · Cited by 28

Design and synthesis of novel diosgenin-triazole hybrids targeting inflammation as potential neuroprotective agents

Huang, Y., Huang, W., Yang, G., Wang, R., & Ma, L. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128092 · Cited by 26

Acute versus chronic inflammatory markers and cognition in older black adults: Results from the Minority Aging Research Study

Boots, E. A., Feinstein, D. L., Leurgans, S. E., Aiken‐Morgan, A. T., Fleischman, D. A., Lamar, M., & Barnes, L. L. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.04.014 · Cited by 26

Inflammation, Nitro-Oxidative Stress, Impaired Autophagy, and Insulin Resistance as a Mechanistic Convergence Between Arterial Stiffness and Alzheimer’s Disease

Hendrickx, J. O., Martinet, W., Dam, D. V., & Meyer, G. R. Y. D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.651215 · Cited by 28

Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations

Mohammed, E. R., Abd-El-Fatah, A. H., Mohamed, A. R., Mahrouse, M. A., & Mohammad, M. A. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107372 · Cited by 24

Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer’s Disease

Uliassi, E., de Oliveira, A. S., Nascente, L. D. C., Romeiro, L. A. S., & Bolognesi, M. L. (2021) · Molecules · doi:10.3390/molecules26185441 · Cited by 28

Human platelets release amyloid peptides β1-40 and β1-42 in response to hemostatic, immune, and hypoxic stimuli

Wolska, N., Celikag, M., Failla, A. V., Tarafdar, A., Renné, T., Torti, M., Canobbio, I., & Pula, G. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.100154 · Cited by 24

Folate deprivation induced neuroinflammation impairs cognition

Shaikh, A., & Roy, H. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137264 · Cited by 25

Association of Aspirin Use with Reduced Risk of Developing Alzheimer’s Disease in Elderly Ischemic Stroke Patients: A Retrospective Cohort Study

Gorenflo, M. P., Davis, P. B., Kendall, E. K., Olaker, V. R., Kaelber, D. C., & Xu, R. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220901 · Cited by 23

Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration

Duggan, M. R., Yang, Z., Cui, Y., Dark, H. E., Wen, J., Erus, G., Hohman, T. J., Chen, J., Lewis, A., Moghekar, A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14142 · Cited by 20

Applications of adeno-associated virus vector-mediated gene delivery for neurodegenerative diseases and psychiatric diseases: Progress, advances, and challenges

Abulimiti, A., Lai, M. S., & Chang, R. C. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111549 · Cited by 23

Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic therapeutics

Hunt, N. J., Wahl, D., Westwood, L. J., Lockwood, G. P., Couteur, D. G. L., & Cogger, V. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114537 · Cited by 21

High resolution 16S rRNA gene Next Generation Sequencing study of brain areas associated with Alzheimer’s and Parkinson’s disease

Emery, D. C., Davies, M., Cerajewska, T. L., Taylor, J., Hazell, M., Paterson, A. R., Allen, S. J., & West, N. X. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1026260 · Cited by 24

Dietary Wheat Amylase Trypsin Inhibitors Impact Alzheimer’s Disease Pathology in 5xFAD Model Mice

Guilherme, M. D. S., Zevallos, V. F., Pesi, A., Stoye, N. M., Nguyen, V. T. T., Radyushkin, K., Schwiertz, A., Schmitt, U., Schuppan, D., & Endres, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176288 · Cited by 21

Prostaglandins in the Inflamed Central Nervous System: Potential Therapeutic Targets

Noakes, P., Sheremeta, C.-L., Yarlagadda, S., & Smythe, M. L. (2024) · Current Drug Targets · doi:10.2174/0113894501323980240815113851 · Cited by 20

Association between non-cystic fibrosis bronchiectasis and the risk of incident dementia: A nationwide cohort study

Kim, S. H., Han, K., Park, J., Park, D. W., Moon, J., Sim, Y. S., Kim, T., Kim, S., Sohn, J. W., Yoon, H. J., et al. (2023) · Chronic Respiratory Disease · doi:10.1177/14799731231222282 · Cited by 20

The Impact of Alcohol-Induced Dysbiosis on Diseases and Disorders of the Central Nervous System

Liu, X., Vigorito, M., Huang, W., Khan, M. A. S., & Chang, S. L. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-10033-4 · Cited by 20

Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer’s Disease

Neshan, M., Malakouti, S. K., Kamalzadeh, L., Makvand, M., Campbell, A., & Ahangari, G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210480 · Cited by 19

Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study

Zheng, B., Su, B., Udeh‐Momoh, C. T., Price, G., Tzoulaki, I., Vamos, E. P., Majeed, A., Ríboli, E., Ahmadi‐Abhari, S., & Middleton, L. T. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.8 · Cited by 19

Alzheimer's disease treatment: The share of herbal medicines.

Soheili, M., Karimian, M., Hamidi, G. A., & Salami, M. (2021) · PubMed Central · doi:10.22038/ijbms.2020.50536.11512 · Cited by 24

Systemic Inflammation Induced Changes in Protein Expression of ABC Transporters and Ionotropic Glutamate Receptor Subunit 1 in the Cerebral Cortex of Familial Alzheimer`s Disease Mouse Model

Puris, E., Auriola, S. O. K., Korhonen, P., Loppi, S. H., Kanninen, K. M., Malm, T., Koıstınaho, J., & Gynther, M. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2021.08.013 · Cited by 19

Exploring the gut-brain axis in alzheimer’s disease treatment via probiotics: evidence from animal studies-a systematic review and meta-analysis

Siripaopradit, Y., Chatsirisakul, O., Ariyapaisalkul, T., & Sereemaspun, A. (2024) · BMC Neurology · doi:10.1186/s12883-024-03978-5 · Cited by 27

Effect of amyloid-β on the redox system activity in SH-SY5Y cells preincubated with lipopolysaccharide or co-cultured with microglia cells

Wiatrak, B., Jawień, P., Matuszewska, A., Szeląg, A., & Kubis-Kubiak, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112880 · Cited by 17

Sex-based differences in effector cells of the adaptive immune system during Alzheimer's disease and related dementias

Lutshumba, J., Wilcock, D. M., Monson, N. L., & Stowe, A. M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106202 · Cited by 20

Tracing the Path between Mushrooms and Alzheimer’s Disease—A Literature Review

Silva, A. M., Preto, M., Grosso, C., Vieira, M., Delerue-Matos, C. M., Vasconcelos, V. M., Reis, M. A., Barros, L., & Martins, R. F. (2023) · Molecules · doi:10.3390/molecules28145614 · Cited by 22

Protective effects of apigenin on the brain transcriptome with aging

Cavalier, A. N., Clayton, Z. S., Wahl, D., Hutton, D. A., McEntee, C. M., Seals, D. R., & LaRocca, T. J. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111889 · Cited by 21

Anti-Inflammatory Diet and Protein-Enriched Diet Can Reduce the Risk of Cognitive Impairment among Older Adults: A Nationwide Cross-Sectional Research

Wang, L., Xian, X., Zhou, M., Xu, K., Cao, S., Cheng, J., Dai, W., Zhang, W., & Ye, M. (2024) · Nutrients · doi:10.3390/nu16091333 · Cited by 20

Serum Thioredoxin-80 is associated with age, ApoE4, and neuropathological biomarkers in Alzheimer’s disease: a potential early sign of AD

Goikolea, J., Gereñu, G., Daniilidou, M., Mangialasche, F., Mecocci, P., Ngandu, T., Rinne, J. O., Solomon, A., Kivipelto, M., Cedazo-Mı́nguez, Á., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00979-9 · Cited by 17

Recent insights into viral infections as a trigger and accelerator in alzheimer's disease

Vlieger, L. D., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103340 · Cited by 16

Association between air pollution and CSF sTREM2 in cognitively normal older adults: The CABLE study

Li, M., Ma, Y., Fu, Y., Liu, J.-Y., Hu, H., Zhao, Y., Huang, L., & Tan, L. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51671 · Cited by 16

Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice

Xu, Y.-M., Lu, F.-M., Xu, H.-C., Zhang, J., Hei, S.-Y., Qiu, Y.-H., Cai, Y.-F., Zhang, S.-J., & Zhao, M. (2023) · Rejuvenation Research · doi:10.1089/rej.2022.0063 · Cited by 15

Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression

Duggan, M. R., Gómez, G., Joynes, C. M., Bilgel, M., Chen, J., Fattorelli, N., Hohman, T. J., Mancuso, R., Cordon, J., Castellano, T., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.002 · Cited by 16

Deterioration of neuroimmune homeostasis in Alzheimer’s Disease patients who survive a COVID-19 infection

Villareal, J. A. B., Bathe, T., Hery, G. P., Phillips, J. L., Tsering, W., & Prokop, S. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03196-3 · Cited by 17

The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer's disease pathology

Anwar, M. M. (2023) · Ibrain · doi:10.1002/ibra.12090 · Cited by 15

Qi-fu-yin attenuated cognitive disorders in 5xFAD mice of Alzheimer's disease animal model by regulating immunity

Yang, X., Ye, T., He, Y., Wen, L., & Cheng, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1183764 · Cited by 15

Repurposing Antimicrobial Protegrin-1 as a Dual-Function Amyloid Inhibitor via Cross-seeding

Tang, Y., Zhang, D., & Zheng, J. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00293 · Cited by 16

CNS-Active p38α MAPK Inhibitors for the Management of Neuroinflammatory Diseases: Medicinal Chemical Properties and Therapeutic Capabilities

Valipour, M., Mohammadi, M., & Valipour, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03829-3 · Cited by 16

Repurposing drugs: promising therapeutic approach against Alzheimer’s disease

Pattanaik, S., Ghose, A., Pakeeraiah, K., Paidesetty, S. K., Prusty, S. K., & Sahu, P. K. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102698 · Cited by 14

One immune cell to bind them all: platelet contribution to neurodegenerative disease

Moore, G. R., Melo-Escobar, I., Stegner, D., & Bracko, O. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00754-4 · Cited by 18

New Approaches to Profile the Microbiome for Treatment of Neurodegenerative Disease

Elmaleh, D. R., Downey, M. A., Kundakovic, L., Wilkinson, J. E., Neeman, Z., & Segal, E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210198 · Cited by 14

Systemic inflammation and disease progression in Alzheimer disease

Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139

O3‐02–01: Systemic cytokines and clinical progression in Alzheimer's disease

Holmes, C., Perry, V. H., Cunningham, C. M., Zotova, E., & Dean, C. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.414 · Cited by 2

Multifactorial Pathologies Promote Inflammation and Enhance vulnerability to Late-Onset Alzheimer’s Disease: Implications for Possible Therapeutic Targets

Daulatzai, M. A. (2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058709114020006 · Cited by 3

Systemic Inflammation and Its Interaction with Alzheimer’s Disease Pathology in Accelerating Cognitive Decline

Chen, D., Walker, K., Albert, M., Walston, J., Langdon, J. M., & Gross, A. L. (2025) · Innovation in Aging · doi:10.1093/geroni/igaf122.4294

Environmental Influences on Neurodegenerative Disease: The Impact of Systemic Inflammation

Perry, V. H. (2011) · The MIT Press eBooks · doi:10.7551/mitpress/9780262015233.003.0025 · Cited by 1